凯普生物 (300639.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

现金流量表(凯普生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 775,073,551.44497,752,472.88263,048,205.572,016,093,428.831,329,673,717.24948,949,382.10620,541,847.13
 收到的税费返还(元) 304,056.87301,013.02191,869.1357,153.1812,658,612.236,332,248.955,987,636.26
 收到其他与经营活动有关的现金(元) 29,422,208.8320,281,353.053,585,189.7966,049,040.2928,762,221.2817,751,001.777,404,604.09
 经营活动现金流入小计(元) 804,799,817.14518,334,838.95266,825,264.492,082,199,622.301,371,094,550.75973,032,632.82633,934,087.48
 购买商品、接受劳务支付的现金(元) 144,995,396.50102,480,925.4954,287,016.33490,102,437.60405,491,127.49310,621,782.55161,373,802.16
 支付给职工以及为职工支付的现金(元) 298,064,756.63209,455,626.34116,786,436.88511,849,350.68379,709,509.12285,093,061.89186,832,155.51
 支付的各项税费(元) 115,959,074.83104,193,559.9686,743,447.31364,733,918.07147,519,198.19132,162,382.9287,657,064.50
 支付其他与经营活动有关的现金(元) 201,391,178.47135,428,855.4173,059,745.64395,916,264.88248,222,919.35173,069,350.54128,892,985.28
 经营活动现金流出小计(元) 760,410,406.43551,558,967.20330,876,646.161,762,601,971.231,180,942,754.15900,946,577.90564,756,007.45
 经营活动产生的现金流量净额(元) 44,389,410.71-33,224,128.25-64,051,381.67319,597,651.07190,151,796.6072,086,054.9269,178,080.03
二、投资活动产生的现金流量
 收回投资收到的现金(元) 580,000,000.00421,955,026.29300,000,000.001,091,908,644.29854,919,990.76728,497,139.34202,150,000.00
 取得投资收益收到的现金(元) 3,316,889.30-788,285.197,636,025.55--534,495.10
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 102,202.80102,120.802,341.0017,740,835.2867,247.4256,039.8237,468.00
 投资活动现金流入小计(元) 583,419,092.10422,057,147.09300,790,626.191,117,285,505.12854,987,238.18728,553,179.16202,721,963.10
 购建固定资产、无形资产和其他长期资产支付的现金(元) 130,471,384.20103,416,933.8443,888,102.10385,321,327.32325,554,524.75252,329,458.30151,218,230.16
 投资支付的现金(元) 285,000,001.00285,000,001.00285,000,000.001,017,178,156.16735,200,000.00596,950,000.00194,200,000.00
 投资活动现金流出小计(元) 415,471,385.20388,416,934.84328,888,102.101,402,499,483.481,060,754,524.75849,279,458.30345,418,230.16
 投资活动产生的现金流量净额(元) 167,947,706.9033,640,212.25-28,097,475.91-285,213,978.36-205,767,286.57-120,726,279.14-142,696,267.06
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 55,318,592.0025,000,000.00-79,857,500.0071,617,500.0061,617,500.001,617,500.00
 收到其他与筹资活动有关的现金(元) ---20,413.88---
 筹资活动现金流入小计(元) 55,318,592.0025,000,000.00-79,877,913.8871,617,500.0061,617,500.001,617,500.00
 偿还债务支付的现金(元) 11,617,500.002,117,500.001,617,500.00147,882,500.0083,681,072.3250,000,000.00-
 分配股利、利润或偿付利息支付的现金(元) 45,124,610.7845,108,701.062,964,501.52160,455,062.01154,358,101.01153,518,731.73765,887.68
 支付其他与筹资活动有关的现金(元) 64,763,853.5236,012,185.3030,553,598.2865,940,329.5156,102,296.3254,769,605.815,920,114.76
 筹资活动现金流出小计(元) 121,505,964.3083,238,386.3635,135,599.80374,277,891.52294,141,469.65258,288,337.546,686,002.44
 筹资活动产生的现金流量净额(元) -66,187,372.30-58,238,386.36-35,135,599.80-294,399,977.64-222,523,969.65-196,670,837.54-5,068,502.44
四、汇率变动对现金及现金等价物的影响(元) -1,615,182.435,955,834.182,594,073.17947,864.761,818,231.27-3,718,258.88-13,738,364.27
五、现金及现金等价物净增加额(元) 144,534,562.88-51,866,468.18-124,690,384.21-259,068,440.17-236,321,228.35-249,029,320.64-92,325,053.74
 加:期初现金及现金等价物余额(元) 761,367,697.61761,367,697.61764,931,888.811,020,436,137.781,024,775,861.201,024,775,861.201,024,775,861.20
 期末现金及现金等价物余额(元) 905,902,260.49709,501,229.43640,241,504.60761,367,697.61788,454,632.85775,746,540.56932,450,807.46
补充资料:
 净利润(元) --129,351,655.63-68,514,447.13-89,357,944.73-
 资产减值准备(元) -74,691,821.62-9,981,979.44--9,271,266.90-
 固定资产和投资性房地产折旧(元) -66,083,602.64-154,320,573.58-65,015,075.05-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -66,083,602.64-154,320,573.58-65,015,075.05-
 无形资产摊销(元) -6,208,871.71-11,233,516.02-4,816,602.29-
 长期待摊费用摊销(元) -9,449,079.06-13,896,245.78-18,492,980.90-
 处置固定资产、无形资产和其他长期资产的损失(元) --791,920.84--7,060,528.61--6,804,852.35-
 固定资产报废损失(元) -121,366.41-143,348.44-218,019.16-
 公允价值变动损失(元) -7,448.94-1,834.96-5,394.06-
 财务费用(元) -246,315.26-4,944,844.45-15,047,162.87-
 投资损失(元) --4,440,642.84--13,944,049.55--4,461,060.92-
 递延所得税(元) --12,495,749.60--59,632,094.60-11,176,113.30-
  其中:递延所得税资产减少(元) --9,568,271.27--15,093,847.65-14,531,415.86-
 递延所得税负债增加(元) --2,927,478.33--44,538,246.95--3,355,302.56-
 存货的减少(元) -2,732,773.52-52,377,001.53-19,529,714.35-
 经营性应收项目的减少(元) -61,214,742.43-873,516,293.66-341,753,870.24-
 经营性应付项目的增加(元) --107,879,362.42--802,728,389.45--474,707,389.83-
 其他(元) --3,138,073.45-11,438,420.81--4,379,114.90-
 现金的期末余额(元) -709,501,229.43-761,367,697.61-775,746,540.56-
 减:现金的期初余额(元) -761,367,697.61-1,020,436,137.78-1,024,775,861.20-
 现金及现金等价物的净增加额(元) --51,866,468.18--259,068,440.17--249,029,320.64-
公告日期 2024-10-302024-08-292024-04-272024-04-242023-10-262023-08-312023-04-25
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院